487 related articles for article (PubMed ID: 12630564)
1. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
2. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
[TBL] [Abstract][Full Text] [Related]
6. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
Murata M
Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
[TBL] [Abstract][Full Text] [Related]
7. A Toll-like receptor recognizes bacterial DNA.
Hemmi H; Takeuchi O; Kawai T; Kaisho T; Sato S; Sanjo H; Matsumoto M; Hoshino K; Wagner H; Takeda K; Akira S
Nature; 2000 Dec; 408(6813):740-5. PubMed ID: 11130078
[TBL] [Abstract][Full Text] [Related]
8. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
9. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
10. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice.
Nicolle D; Fremond C; Pichon X; Bouchot A; Maillet I; Ryffel B; Quesniaux VJ
Infect Immun; 2004 Dec; 72(12):6994-7004. PubMed ID: 15557622
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus.
Han SB; Yoon YD; Ahn HJ; Lee HS; Lee CW; Yoon WK; Park SK; Kim HM
Int Immunopharmacol; 2003 Sep; 3(9):1301-12. PubMed ID: 12890428
[TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
13. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
15. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the immuno-activation mechanism of OK-432--phagocytosis, release of active components and TLR4 signaling].
Tano T; Okamoto M; Oshikawa T; Ahmed SU; Sato M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1767-9. PubMed ID: 15553709
[TBL] [Abstract][Full Text] [Related]
17. [Anti-tumor immunity induced by OK-432-derived DNA].
Oshikawa T; Okamoto M; Ahmed SU; Tano T; Sasai A; Kan S; Sato M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1559-61. PubMed ID: 16315868
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4.
Braedel S; Radsak M; Einsele H; Latgé JP; Michan A; Loeffler J; Haddad Z; Grigoleit U; Schild H; Hebart H
Br J Haematol; 2004 May; 125(3):392-9. PubMed ID: 15086422
[TBL] [Abstract][Full Text] [Related]
20. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
